EPTIS
BAM Logo

PREE - Human serum biological preeclampsia markers control

[PREE - Contrôle marqueurs biologiques de la pré-éclampsie]

EPTIS factsheet 1577009 | Last revision 2026-06-05 | URL: https://www.eptis.bam.de/pts1577009 https://www.eptis.bam.de/pts1577009

PT provider
PT provider PROBIOQUAL PROBIOQUAL
Based in France
Language(s) French / English
Remarks
Keywords
Product groups Health care / medical devices
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human Serum PLGF (placental growth factor) -
sFlt-1 -
sFlt-1/PlGF Ratio -
PAPP-A -
First-trimester pregnancy preeclampsia risk assessment -
Aims of the PT scheme
Target group of participants Laboratory medecine / clinical biologists / no geographical restriction
Linked to specific legislation / standards ISO 17043 / ISO 15189
Additional, subsidiary aims validation of testing methods
Number of participants 45
Accredited or otherwise reviewed by a 3rd party

no

Operation is commissioned / requested by no
Fees and frequency
Participation fee 420 € in 2026
Regularly operated Yes (4 times per year, 8 vials)
Year of first operation 2020
Contact details of the PT provider
Provider Contact person
PROBIOQUAL
7 Rue Antoine Lumière
69008 - LYON
France

Phone: +33472653490
Fax:
Web: https://www.probioqual.com https://www.probioqual.com
Dr Régine CARTIER
Phone: +33472653490
Fax:
Email: r.cartier@probioqual.com r.cartier@probioqual.com
If you find any mistakes please contact the responsible EPTIS coordinator in France, Mr Patrick Bironneau. Mr Patrick Bironneau.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5